Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward F Fritsch

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Nature|July 6, 2017
An immunogenic personal neoantigen vaccine for patients with melanomaPatrick A Ott, Zhuting Hu, Derin B Keskin, et al.
Nature Medicine|January 22, 2021
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanomaZhuting Hu, Donna E Leet, Rosa L Allesøe, et al.
Nature|March 16, 2018
Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanomaPatrick A Ott, Zhuting Hu, Derin B Keskin, et al.
Cell|July 11, 2025
A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanomaEryn Blass, Derin B Keskin, Chloe R Tu, et al.
Nature|February 5, 2025
A neoantigen vaccine generates antitumour immunity in renal cell carcinomaDavid A Braun, Giorgia Moranzoni, Vipheaviny Chea, et al.
Nature|December 21, 2018
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trialDerin B Keskin, Annabelle J Anandappa, Jing Sun, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Nature|July 6, 2017
An immunogenic personal neoantigen vaccine for patients with melanomaPatrick A Ott, Zhuting Hu, Derin B Keskin, et al.
Nature Medicine|January 22, 2021
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanomaZhuting Hu, Donna E Leet, Rosa L Allesøe, et al.
Nature|March 16, 2018
Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanomaPatrick A Ott, Zhuting Hu, Derin B Keskin, et al.
Cell|July 11, 2025
A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanomaEryn Blass, Derin B Keskin, Chloe R Tu, et al.
Nature|February 5, 2025
A neoantigen vaccine generates antitumour immunity in renal cell carcinomaDavid A Braun, Giorgia Moranzoni, Vipheaviny Chea, et al.
Nature|December 21, 2018
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trialDerin B Keskin, Annabelle J Anandappa, Jing Sun, et al.
Pageof 3